Open Access Highly Accessed Research article

Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus

Richard Furie*, William Stohl, Ellen M Ginzler, Michael Becker, Nilamadhab Mishra, Winn Chatham, Joan T Merrill, Arthur Weinstein, W Joseph McCune, John Zhong, Wendy Cai, William Freimuth and the Belimumab Study Group

Arthritis Research & Therapy 2008, 10:R109 doi:10.1186/ar2506

No comments have yet been made on this article.

Post a comment